Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Baird Downgrades Myovant Sciences to Neutral, Raises Price Target to $27

Author: Benzinga Newsdesk | October 24, 2022 03:01pm

Baird analyst Brian Skorney downgrades Myovant Sciences (NYSE:MYOV) from Outperform to Neutral and raises the price target from $20 to $27.

Posted In: MYOV